Woodline Partners LP - ACUMEN PHARMACEUTICALS INC ownership

ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 62 filers reported holding ACUMEN PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of ACUMEN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$1,730,258
-24.8%
426,1720.0%0.02%
-22.6%
Q4 2022$2,301,329
-46.9%
426,172
-1.4%
0.03%
-49.2%
Q3 2022$4,335,000
+116.4%
432,158
+1.4%
0.06%
+96.8%
Q2 2022$2,003,000
+2.2%
426,170
-15.0%
0.03%
-3.1%
Q1 2022$1,960,000
-39.7%
501,236
+4.3%
0.03%
-31.9%
Q4 2021$3,249,000
-53.4%
480,681
+2.5%
0.05%
-58.8%
Q3 2021$6,966,000468,7940.11%
Other shareholders
ACUMEN PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Sands Capital Ventures, LLC 3,417,075$14,180,8614.20%
Knollwood Investment Advisory, LLC 1,628,510$6,758,3173.16%
Altium Capital Management LP 650,000$2,697,5001.41%
RA Capital Management 14,932,063$61,968,0611.22%
GREAT POINT PARTNERS LLC 1,074,101$4,457,5190.81%
Boxer Capital, LLC 2,206,983$9,158,9790.49%
Deep Track Capital, LP 2,513,044$10,429,1330.40%
Parkman Healthcare Partners LLC 499,814$2,074,2280.38%
Rock Springs Capital Management LP 2,812,579$11,672,2030.31%
Ghost Tree Capital, LLC 150,000$622,5000.20%
View complete list of ACUMEN PHARMACEUTICALS INC shareholders